Atrial fibrillation with RVR

Revision as of 18:21, 8 September 2014 by Ostermayer (talk | contribs)

Unstable

  • Synchronized cardioversion (100-200J)
  • Indications: ischemic CP, SBP < 90, acute pulmonary edema, AMS
  • If shock doesn't work:
  1. Verify not preexcitation
  2. Incr diastolic BP to perfuse the heart
    1. Push-dose phenyleprhine
      1. Will maintain BP when give rate-control meds
      2. 50-200mcg q2-5min w/ goal DBP >60
  3. Amiodarone 150mg over 10min OR diltiazem 2.5mg/min until HR<100 or max 50mg

Stable

  • Goal <120bpm
    • Make sure you not slowing down a normal physiologic response (e.g. fever, hypoxia, etc)

Cardioversion

  • Consider for:
    • Symptoms <48hr
    • New diagnosis
    • No history of similar episodes
    • No LV dysfunction
    • No mitral valve disease
    • No prior thromboembolic event
    • Already Anticoagulated


Calcium-Channel Blockers

  • Preferred in patients with chronic lung such as Asthma and COPD[1]

Contraindications:

  1. Decompensated heart failure
  2. Preexcitation (especially in pediatrics)
    • Significant hypotension

Diltiazem

  • Bolus 0.25 mg/kg (average adult dose 20mg) over 2 min
  • If, after 15min 1st dose is tolerated but inadequate re-bolus 0.35 mg/kg
  • If patient responds start infusion at 5-15mg/hr or give PO dilt 30mg QID


Beta-Blockers

  • Particularly useful when A-fib a/w exercise, after acute MI, or w/ thyrotoxicosis
  • Also long-term beta blocker improves patient survival whereas non-dihydropyridine calcium channel blockers may even worsen outcomes. Important to consider if a patient will most likely be started on a beta blocker upon discharge then strongly consider using the agent for acute conversion if they do not have any relative contraindications.[2][3]

Contraindications:

  1. COPD
  2. Asthma
  3. Decompensated heart failure
  4. Hypotension

Metoprolol

  • Bolus 2.5-5mg IVP over 2min q5min up to 3 doses
  • If patient responds orally load with 25-50mg

Esmolol

  • Use if unsure whether patient will tolerate a beta blocker since the duration of action is only 10 minutes
  • Bolus 0.5 mg/kg over one minute, followed by 50 µg/kg/min
  • If, after 4min response is inadequate, re-bolus followed by infusion of 100 µg/kg/min
  • If, after 4min response is still inadequate, try final bolus followed by infusion of 150 µg/kg/min
  • If necessary, infusion can be increased to maximum of 200 µg/kg/min after another four minutes

Digoxin

  • Consider as initial therapy for pts with LV dysfunction who:
    • Do not achieve rate control targets on beta blockers alone
    • Cannot tolerate addition of or increased doses of beta blocker due to decompensated CHF
    • Would have digoxin added anyway to improve CHF symptoms independent of A-fib
  • Consider as initial therapy in pts with severe hypotension
  • Consider as 2nd agent in pts in whom IV BB or IV CCB has failed to control their rate
  • May take up to 6-8 hours to work
  • Dosing
    • 0.25 mg IV q2hr up to 1.5 mg, then 0.125-0.25 mg PO or IV QD
    • Adjust dose in presence of renal failure, amiodarone, etc

Amiodarone

  • Consider for pts with decompensated heart failure or those with accessory pathways
  • 2nd-line agent for chronic rate control when BBs and CCBs, alone, combined, or when used with digoxin, are ineffective
  • Load 5-7 mg/kg IV over 30 min; then 1200 mg over 24hr via continuous infusion or in divided oral doses

Stable and Asymptomatic

If mild or no symptoms and pulse only mildly elevated (<120bpm) ok to manage with PO meds

Evidence of preexcitation

  1. Avoid AV nodal agents
  2. Unstable:
    1. Unsynchronized cardioversion (200J)
    2. Procainamide (if cardioversion unsuccessful)
      1. 20-50 mg/min until arrhythmia is controlled, hypotension occurs, QRS complex widens by 50% of original width, or total of 17 mg/kg is given; followed by continuous infusion of 1-4 mg/min
  3. Stable:
    1. Try to avoid cardioversion without adequate anticoagulation

See Also

External Links

[ALiEM - BB vs CCB] [Crashing Afib - EMCrit]

Source

  1. Short PM, Lipworth SI, Elder DH, Schembri S, Lipworth BJ. Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study. BMJ. 2011 May 10;342:d2549
  2. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999 Jun 12;353(9169):2001-7
  3. Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II–DAVIT II). Am J Cardiol. 1990 Oct 1;66(10):779-85